Major factors associated with worldwide dermatophytosis predominance

Falah Hasan Obayes AL-Khikani

doi:10.4103/mgmj.mgmj_64_20

LETTER TO THE EDITOR

Year : 2020 | Volume : 7 | Issue : 4 | Page : 232-233

Major factors associated with worldwide dermatophytosis predominance

Falah Hasan Obayes AL-Khikani
Department of Microbiology, Al-Shomalli General Hospital, Babil, Iraq

Date of Submission	28-Jun-2020
Date of Decision	10-Sep-2020
Date of Acceptance	10-Sep-2020
Date of Web Publication	09-Dec-2020

Correspondence Address:
Dr. Falah Hasan Obayes AL-Khikani
Department of Microbiology, Al-Shomalli General Hospital, Babil.
Iraq

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mgmj.mgmj_64_20

How to cite this article:
AL-Khikani FH. Major factors associated with worldwide dermatophytosis predominance. MGM J Med Sci 2020;7:232-3

How to cite this URL:
AL-Khikani FH. Major factors associated with worldwide dermatophytosis predominance. MGM J Med Sci [serial online] 2020 [cited 2021 Mar 8];7:232-3. Available from: http://www.mgmjms.com/text.asp?2020/7/4/232/302806

Dear Editor,

Dermatophytosis is the disease that is mainly caused by different species of dermatophytes within the cutaneous layer of the skin. It has contagious properties to spread from person to another also from the animal to the human. The skin, hair, and nail of all types of mammals, including humans, are under the risk of developing dermatophytosis.^[1]

Several factors can be associated with a high prevalence of dermatophytosis such as high temperature and humidity in tropical and subtropical regions,^[2] and type of geographical region which is reflected by the fact that the infection is more common in rural areas than in urban regions.^[3],[4]

Patients living in low socioeconomic conditions are predisposed to this infection compared to those than those in middle and high socioeconomic status and tinea infections are more common in those who receive immunosuppressive drugs and in people suffering from diseases like AIDS.^[5] Moreover, close contact with animals^[6],[7] and prolonged use of antibiotics and corticosteroids^{[8],[9],[10],[11],[12]} also make individuals susceptible to develop tinea infection.

The chronic diseases or disorders in the human body also play a role in the distribution of infection as found among patients with diabetes.^[13] The incubation period on the human skin for the development of dermatophytosis is usually from 1 to 2 weeks.^[1] This short time of incubation is considered a risk factor that assists in the early spreading of the disease.

Moisture and warm conditions are the most encouraging factors for the development of Dermatophytosis in tropical countries.^[14] These factors, along with increased sweating resulting from outdoor physical human activities in hot weather and low degree of hygiene, are also associated with the prevalence of dermatophytosis^{[15],[16],[17],[18],[19]} [Figure 1].

Figure 1: Some factors associated with dermatophytosis

Click here to view

Conclusion

Currently, there exists a high prevalence of dermatophyte infection in the world. Humidity and warm temperature are the most important factors along with poor medical care for an increase in the epidemic spread of skin mycoses including dermatophytosis. A thorough understanding of the factors and causes associated with dermatophyte infection may be crucial to control and prevent a high prevalence of this worldwide contagious fungal infection.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest

References

1.	AL-Khikani FH Dermatophytosis a worldwide contiguous fungal infection: Growing challenge and few solutions. Biomed Biotechnol Res J 2020;4:22-7.
2.	Gadadavar S, Shilpa HS, Patil CS, Vinay PS, Shettar N Clinico-mycological study of dermatophytosis at a tertiary care hospital in Belagavi, Karnataka, India. Int J Curr Microbiol Appl Sci 2018;7:1872-80.
3.	Al Sheikh H Epidemiology of dermatophytes in the Eastern province of Saudi Arabia. Res J Microbiol 2009;4:229-39.
4.	AL-Khikani FH Epidemiological and diagnostic studies for the surveillance of Entamoeba moshkovskii. Hamdan Med J 2020;13:78-81.
5.	Negi N, Tripathi V, Choudhury RC, Bist JS, Kumari N, Chandola I Clinicomycological profile of superficial fungal infections caused by dermatophytes in a tertiary care centre of North India. Int J Curr Microbiol Appl Sci 2017;6:3220-7.
6.	AL-Khikani FH Pulmonary mycoses treated by topical amphotericin B. Biomed Biotechnol Res J 2020;4:33-9.
7.	AL-Khikani FH, Auda Ga, Ayit AS Correlation study between urinary tract bacterial infection and some acute inflammatory responses. Biomed Biotechnol Res J 2019;3:236-9.
8.	Obayes AL-Khikani FH, Kadim BJ, Ayit AS, Abidalali MH Evaluation cephalosporins resistance in pathogenic bacteria isolated clinically. World News Nat Sci2020;31:110-9.
9.	AL-Khikani FH, Abadi RM, Ayit AS Emerging carbapenemase Klebsiellaoxytoca with multidrug resistance implicated in urinary tract infection. Biomed Biotechnol Res J 2020;4:56-60.
10.	Al-Khikani FH, Kadem BJ Unusual false-negative serum human chorionic gonadotropin detected by qualitative immunoassay: A case report of two Iraqi women. J Med Sci Res 2020;3:81-3.
11.	AL-Khikani FH, Almosawey HA, Hameed RM, Alhussain BA, Ayit AS, Al-Ibraheemi MK, et al. Prevalence of Entamoebahistolytica and Giardia lamblia associated with infectious diarrhea in AlShomally population, Babil, Iraq. Biomed Biotechnol Res J 2019;3:245-8. [Full text]
12.	Weitzman I, Summerbell RC The dermatophytes. Clin Microbiol Rev 1995;8:240-59.
13.	Pragya K, Rameshwari T, Harish K, Kalsi AS Clinical manifestations and diagnostic challenges of tinea faciei. Int J Curr Microbiol Appl 2017;6:1286-94.
14.	Havlickova B, Czaika VA, Friedrich M Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51:2-15.
15.	AL-Khikani FH. Challenges in fungal treatment: A serious public health problem. Indian J Med Spec2020;11:171. [Full text]
16.	AL-Khikani FH. Antimicrobial resistance profile among major bacterial pathogens in Southern Babil, Iraq. Galician Med J2020;27:55.
17.	Al-Khikani FH, Almosawey HA, Abdullah YJ, Al-Asadi AA, Hameed RM, Hasan NF, et al. Potential antiviral properties of antifungal drugs. J Egypt Women’s Dermatologic Soc 2020;17:185.
18.	Al‑Janabi A, Al‑Khikani F Prophylaxis and therapeutic ability of inactivated dermatophytic vaccine against dermatophytoses in rabbit as an animal model. Turk J Pharm Sci 2020;17:187-90.
19.	Al‑Janabi A, Al‑Khikani F Dermatophytoses: A short definition, pathogenesis, and treatment. Int J Health Allied Sci 2020;9:210.